DRDR vs. XGES ETF Comparison
Comparison of iShares Healthcare Innovation UCITS ETF (DRDR) to Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc GBP (XGES)
DRDR
iShares Healthcare Innovation UCITS ETF
DRDR Description
The Fund seeks to track the performance of an index composed of developed and emerging market companies which are generating significant revenues from specific sectors focused on pushing the boundaries in medical treatment and technology.
Grade (RS Rating)
Last Trade
£580.63
Average Daily Volume
21,316
Number of Holdings
*
32
* may have additional holdings in another (foreign) market
XGES
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc GBP
XGES Description
NAGrade (RS Rating)
Last Trade
£22.87
Average Daily Volume
125
Number of Holdings
*
16
* may have additional holdings in another (foreign) market
Performance
Period | DRDR | XGES |
---|---|---|
30 Days | -5.34% | -4.99% |
60 Days | -4.17% | -3.62% |
90 Days | 0.93% | -0.61% |
12 Months | -2.46% | -7.83% |
13 Overlapping Holdings
Symbol | Grade | Weight in DRDR | Weight in XGES | Overlap | |
---|---|---|---|---|---|
0A45 | B | 1.18% | 5.61% | 1.18% | |
0HAV | C | 1.68% | 4.14% | 1.68% | |
0IRF | F | 0.38% | 0.11% | 0.11% | |
0J5Q | C | 1.4% | 1.97% | 1.4% | |
0J8Z | F | 0.84% | 3.87% | 0.84% | |
0L35 | B | 1.34% | 1.03% | 1.03% | |
0QNO | B | 1.25% | 5.14% | 1.25% | |
0QOK | F | 0.05% | 4.2% | 0.05% | |
0QOK | F | 1.08% | 4.2% | 1.08% | |
0QOK | F | 1.08% | 0.21% | 0.21% | |
0QOK | F | 0.05% | 0.21% | 0.05% | |
0RLT | A | 1.24% | 1.81% | 1.24% | |
ONT | F | 0.13% | 0.13% | 0.13% |
DRDR Overweight 21 Positions Relative to XGES
DRDR: Top Represented Industries & Keywords
XGES: Top Represented Industries & Keywords
Industries:
Biotechnology
Keywords:
Biotechnology
Rare Diseases
Cancer
Genomics
Genotyping
Infectious Diseases
Orphan Drugs
Agilent Technologies
Analytical Chemistry
Asset Management
Astrazeneca
Biopharmaceutical
Biopsy
Biotechnology Industry
Breast Cancer
Bristol Myers Squibb
Cancer Immunotherapy
Cancer Screening
Chemical Pathology
Chemistry